Oxehealth Limited (operating as LIO Health)

Bee House, Eastern Avenue, Milton Park, Abingdon, England, OX14 4SB, United Kingdom  All United Kingdom companies → Founded 2012
Medical Device / Hardware Mental Health Platform Wearables / RPM
Psychiatry Pulmonology Sleep Medicine
Mental & Behavioral Health AI Wearables & Remote Monitoring (RPM)
Series A — $22.1M+

Products

Oxevision Sleep Device
Oxehealth Limited (operating as LIO Health)
Mental & Behavioral Health AI
Oxevision Sleep Device is an FDA-cleared AI-powered contactless patient monitoring solution by Oxehealth Limited (LIO Health) for sleep assessment in hospitals and mental health facilities, providing insights from video analysis without physical contact.

See all 1 product →

About Oxehealth Limited (operating as LIO Health)

LIO Health, formerly Oxehealth Limited, is a healthcare AI company specializing in vision-based patient monitoring and management systems for inpatient mental health settings. Originating from the University of Oxford’s Institute of Biomedical Engineering in 2012, the company has developed a comprehensive platform designed to transform mental health services through advanced digital rounding, ambient monitoring, and compliance tools.

The LIO platform utilizes a patented infrared system to remotely monitor patients, providing contactless measurement of sleep patterns and vital signs through FDA-cleared software. This technology offers additional insights into patient activity without requiring physical contact or disturbing patients during their care. The aim is to enable clinicians to conduct observations and maintain patient safety from any location within a unit, including shared spaces and corridors, thereby enhancing patient care and improving operational efficiency in mental health hospitals. The platform also provides operational oversight capabilities for hospital leaders, ensuring care delivery meets regulatory standards and identifying areas for improvement.

Focus Areas

Contactless patient monitoring mental health behavioral health inpatient care vital signs monitoring activity monitoring fall prevention self-harm prevention sleep monitoring digital observations clinical AI

Business Intelligence

Key InvestorsOrawealth, IP Group, Oxford Technology & Innovations EIS Fund (OTIF), ORA Capital Partners Ltd., Top Technology Ventures Limited, Adams PLC
PartnershipsSummitStone Health Partners (US), NHS England mental health trusts (approximately half of them)
TechnologyCloud-native, vision-based patient monitoring platform (LIO platform, formerly Oxevision), contact-free optical sensors, infrared-sensitive cameras, AI and machine learning algorithms, Software-as-a-Service (SaaS) delivery model, digital rounding, ambient monitoring, compliance reporting, EPR integration
FDA Clearances2 cleared products (estimated)

What Physicians Need to Know

Specialization in Inpatient Mental Health
LIO Health (formerly Oxehealth) offers an all-in-one platform specifically designed for inpatient mental health services, integrating digital rounding, ambient monitoring, and compliance reporting.
Contactless Patient Monitoring
Utilizes a patented infrared system and FDA-cleared software to remotely and contact-free measure vital signs (pulse, breathing rate), sleep patterns, and patient activity, eliminating the need for wearables or physical disturbance.
Enhanced Safety & Operational Efficiency
The platform is proven to reduce safety incidents such as self-harm, falls, and assaults, while also saving significant staff time and improving overall operational efficiency and cost savings for mental health facilities.
Data-Driven Insights & Compliance
Provides tools for rich data collection, reinforces adherence to clinical protocols, offers automated daily summaries, audit trails, and comprehensive compliance reporting, giving leaders clear oversight of care delivery.
Evidence-Based Impact
The effectiveness of LIO's platform is supported by robust, peer-reviewed evidence, demonstrating measurable improvements in patient safety, quality of care, and operational efficiency.
Physician Tip

For physicians, LIO Health stands out by offering a non-intrusive way to gain continuous, objective insights into patient well-being, especially in mental health settings. The contactless monitoring system provides real-time data on vital signs, sleep, and activity, enabling proactive intervention and enhancing patient safety without disturbing their rest or privacy. This leads to reduced critical incidents (e.g., self-harm, falls, assaults) and frees up clinical staff from routine observation tasks, allowing them to focus on more complex and therapeutic aspects of care. The platform's ability to provide a 'full medical context' through its AI, reasoning from a patient's complete health data, can significantly improve clinical decision-making and care coordination, ensuring a more informed and personalized approach to patient management.

LIO Health's solutions are designed to fit effortlessly into existing clinical protocols and systems. While specific integration partners are not extensively detailed, the platform emphasizes seamless integration with existing systems to automate workflows and enhance data management. It also supports exporting reports for integration into electronic patient records.

Products by Oxehealth Limited (operating as LIO Health)

1 product in the directory

Oxevision Sleep Device
Oxehealth Limited (operating as LIO Health)
Mental & Behavioral Health AI
Oxevision Sleep Device is an FDA-cleared AI-powered contactless patient monitoring solution by Oxehealth Limited (LIO Health) for sleep assessment in hospitals and mental health facilities, providing insights from video analysis without physical contact.

What the Web Says

Oxehealth Limited, operating as LIO Health, provides a contactless patient monitoring platform called Oxevision (now LIO) for mental health inpatient facilities. The technology uses infrared cameras to monitor vital signs, sleep patterns, and activity, aiming to improve patient safety and staff efficiency. While the company and its partners highlight significant reductions in self-harm and falls, the use of the technology, particularly continuous in-bedroom camera monitoring, has raised serious ethical and data privacy concerns among patient advocacy groups and in a public inquiry.

Overall: Mixed

Strengths

  • Contactless patient monitoring for vital signs, sleep, and activity.
  • Aims to reduce incidents like self-harm and falls in mental health settings.
  • Provides clinical insights to help staff plan care and intervene proactively.
  • Can lead to operational savings and improved staff efficiency by digitizing observations and reducing administrative burden.
  • Developed in collaboration with clinicians, patients, and carers.
  • FDA-cleared software for contactless measurement of sleep patterns and vital signs.

Limitations

  • Significant ethical and data privacy concerns regarding continuous in-bedroom camera monitoring.
  • Described as 'intrusive and unnecessary' as a routine practice by the HM Chief Inspector of Prisons.
  • Research into the efficacy of surveillance technologies in inpatient settings is often of 'low methodological quality' and lacks lived experience involvement.
  • Concerns about accurate and complete information provided to patients regarding camera monitoring and data collection.
  • Lack of clear guidance from the company on ethical and lawful use, leaving NHS trusts to develop their own, often inadequate, policies.
  • Some NHS Trusts have discontinued use due to patient feedback and mounting concerns.

Based on reviews from: NSUN website, Oxford University Innovation, DigitalHealth.London, Medical Technology Enterprise Consortium | MTEC, HLTH, LIO | A new chapter in mental health care, IP Group, GOV.UK, LIO Health, eMHIC, Tracxn, Bindmans client, Stop Oxevision, seek expedited investigation by the Information Commissioner's Office into Oxevision data protection issues, GlobeNewswire, Stopping Oxevision: An update and a request for your help

Last updated: 2026-07-20

Videos

News, demos, and interviews about Oxehealth Limited (operating as LIO Health).

Loading videos...

Videos load interactively. If none appear, search YouTube for Oxehealth Limited (operating as LIO Health) →

View all on YouTube

Press & Coverage

HLTH
LIO Unveils Comprehensive Platform for Inpatient Mental Health Care
LIO, formerly Oxehealth, launched a new platform for inpatient mental health services, featuring digital rounding, ambient monitoring, and compliance tools. The company has expanded its U.S. footprint by 500% since early 2025.
2025-08
IP Group
Oxehealth Rebrands as LIO, Launching Next-Gen Platform to Transform Inpatient Mental Health Care
Oxehealth announced its relaunch as LIO, introducing a next-generation operating platform for mental health hospitals, building on 15 years of collaboration with NHS mental health trusts. The new platform integrates ambient monitoring, digital observations, and management insights.
2025-08
GlobeNewswire
LIO Launches Next-Generation Inpatient Mental Health Platform with Advanced Rounding, Monitoring, and Compliance Tools
LIO, previously Oxehealth, launched an all-in-one platform for inpatient mental health services, which includes a compliance reporting suite, digital observations, and adaptive monitoring modes. The company has seen a 500% expansion in its U.S. presence since the beginning of 2025.
2025-08
PR Newswire
Alpha Global partners with LIO to redefine Mental Health Care in Australia
Alpha Global announced an exclusive distribution agreement for LIO's mental health operating platform in Australia and New Zealand. LIO's platform combines ambient monitoring, digital observations, and management insights.
2025-08
NSUN website
NHS Trust forced to admit potential misuse of Oxevision (now u201cLIOu201d)
During the Lampard Inquiry, an NHS Trust acknowledged the potential misuse of Oxevision (now LIO) camera systems in mental health patient bedrooms, raising concerns about privacy and consent. The company, Oxehealth/LIO, conceded that the vision-based monitoring systems record video footage 24/7.
2025-10
PR Newswire
Oxehealth Granted Regulatory Clearances for Mental Health Sleep Monitoring
Oxehealth announced FDA and EU clearances for its new sleep monitoring software, expanding its contactless patient monitoring platform for acute mental health. The technology assesses sleep/wake patterns with accuracy comparable to polysomnography.
2024-05
Medical Device Network
Oxehealth secures FDA and CE mark approvals for its sleep monitoring solution
Oxehealth received US FDA and CE Mark approvals for its new sleep monitoring solution, Oxevision, a contactless patient monitoring platform for acute mental health. The system provides automated daily outputs to support clinical decision-making.
2024-05
Research journals (PLOS Digital Health)
Economic impact of a vision-based patient monitoring system across five NHS mental health trusts
A study published in PLOS Digital Health evaluated the economic impact of Oxevision (Oxehealth Ltd) across five NHS mental health trusts, highlighting its role as an assistive tool for patient safety through non-contact physiological and physical monitoring.
2024-09

Frequently Asked Questions

LIO Health, formerly Oxehealth, offers an all-in-one platform for inpatient mental health services, encompassing digital rounding, ambient monitoring, and compliance reporting. This AI-powered system uses a patented infrared camera to remotely and contactlessly monitor patient vital signs, sleep patterns, and activity, aiming to enhance patient safety, reduce adverse incidents, and improve staff efficiency in mental health facilities.
LIO Health adheres to stringent regulatory and data privacy standards, holding certifications like ISO 27001, ISO 27701, and ISO 13485. Their products comply with key medical device regulations, including FDA clearance and CE marking, as well as data protection laws such as HIPAA and GDPR.
LIO Health operates on a Software-as-a-Service (SaaS) model, providing a recurring revenue stream, with one source indicating a cost of approximately u00a330,240 per unit per year, including licensing, installation, and cabling. Implementing the platform can lead to significant operational efficiencies and cost savings, with research suggesting a 100-bed facility could prevent over 400 safety incidents and save around $700,000 annually.
LIO Health offers comprehensive support, including an end-to-end service from initial deployment to continuous improvement. They provide tailored training plans, delivered onsite, virtually, or through their online portal, OxeAcademy, and offer on-site assistance during go-live.
LIO Health has a history of extensive collaboration, developed over 15 years with healthcare providers globally, including partnerships with half of NHS England's mental health providers. The company originated as a spinout from the University of Oxford's Institute of Biomedical Engineering, and their solutions are co-created with patients, carers, clinicians, and leaders.
LIO Health, founded in 2012 and rebranded from Oxehealth in August 2025, has raised over $7 million in funding and reported u00a34.75 million in annual revenue as of December 2023, with a 500% expansion in its U.S. footprint since early 2025. However, the company's technology has faced scrutiny during the Lampard Inquiry in October 2025, with concerns raised about potential misuse and ethical implications of constant camera-based surveillance in psychiatric inpatient bedrooms.

Related Companies

CAIMed, the Lower Saxony Center for Artificial Intelligence and Causal Methods in Medicine, is a research institution dedicated to advancing personalized healthcare through innovative AI and causal methodologies. The center aims to address widespread diseases such as cancer, cardiovascular diseases, and infections by linking research data, clinical data, and patient care data. This integrated approach, […]

Autoderm is a health technology company that provides a CE-marked AI dermatology screening API designed to analyze smartphone photos for various skin conditions. The company’s AI models are trained on a proprietary database of amateur smartphone images of skin diseases and are accessible via an API that can be integrated into various platforms, including electronic […]

OCTA is an AI-powered finance automation platform that aims to streamline financial operations and accelerate cash flow for businesses, particularly SMEs and enterprises in the Middle East, with a strong presence in the UAE and Saudi Arabia. The platform utilizes AI agents to automate tasks across the entire contract-to-cash cycle, including contract creation, e-signing, invoicing, […]

Skin Analytics is a British health technology company dedicated to the early and accurate diagnosis of skin cancer, aiming to reduce mortality from the disease. They achieve this through their flagship product, DERM, an AI-powered medical device. DERM is designed to provide dermatologist-quality skin cancer assessments, making them more accessible and reducing the burden on […]

MedTalk AI is an Australian-based healthcare AI company focused on streamlining clinical documentation for physicians and other healthcare professionals. The company’s flagship product is an ambient AI medical scribe that listens to real clinical conversations and converts them into structured, accurate notes in real-time. This technology aims to free clinicians from the burden of manual […]

allergoSMART is a healthcare AI company that offers the world’s first AI-based complete solution for personalized mite allergen avoidance. The company’s system, allergoSMART, provides a unique AI digital solution for individuals with dust mite allergies, combining targeted prevention and treatment through comprehensive home environment optimization. [3] It integrates symptom tracking, telemedicine, and air purification into […]

AI Tool Finder
AI-powered search. Results may not be comprehensive.